已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Laparoscopic Partial Splenectomy: A Critical Appraisal of an Emerging Technique. A Review of the First 457 Published Cases

医学 脾切除术 剖腹手术 外科 遗传性球形红细胞增多症 腹腔镜检查 止血 不利影响 球形红细胞增多 普通外科 内科学 脾脏
作者
Andrea Romboli,Alfredo Annicchiarico,Andrea Morini,Carolina Castro Ruiz,Lorenzo Pagliai,Filippo Montali,Renato Costi
出处
期刊:Journal of Laparoendoscopic & Advanced Surgical Techniques [Mary Ann Liebert]
卷期号:31 (10): 1130-1142 被引量:5
标识
DOI:10.1089/lap.2020.0769
摘要

Background: Laparoscopic partial splenectomy (LPS) may allow avoiding total splenectomy (TS) complications and maximizing the advantages of mini-invasive approach. The objective of this review is to assess feasibility and safety of LPS, to compare this approach with alternative options. Materials and Methods: A literature review of articles reporting LPS is performed. Several parameters, including age, indication, surgical technique, devices used for splenic section/hemostasis, adverse outcomes, including morbidity/mortality, conversions to open surgery, conversions to TS, operative time (OT), and hospital stay (HS), are analyzed. Articles comparing LPS' results with those of open partial splenectomy and laparoscopic TS are also analyzed. Results: Fifty-nine articles reporting 457 LPS were included. Patients' characteristics varied widely, concerning age and indications, including hematological disease (hereditary spherocytosis, drepanocytosis), splenic focal masses, and trauma. Several technical options are reported. Mean OT and HS are 128 ± 43.7 minutes and 4.9 ± 3.8 days, respectively. No mortality and 5.7% morbidity are reported. Conversion rates to open surgery and to TS are 3.9% and 3.7%, respectively. Conclusions: In conclusion LPS is feasible and safe, with no mortality, low morbidity, and low conversion rates to laparotomy and to TS. LPS may be accomplished by various techniques and tools. Major complications are sporadically reported, thus potential risks should not be underestimated.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
热带蚂蚁完成签到 ,获得积分10
1秒前
3秒前
科研通AI2S应助euy采纳,获得10
4秒前
光之战士完成签到 ,获得积分10
6秒前
Hello应助hibiwi采纳,获得20
7秒前
Divine发布了新的文献求助10
7秒前
细心天德完成签到 ,获得积分10
9秒前
科研通AI2S应助维夏十一采纳,获得10
10秒前
桐桐应助科研通管家采纳,获得10
14秒前
CUT应助科研通管家采纳,获得10
14秒前
所所应助科研通管家采纳,获得10
15秒前
华仔应助科研通管家采纳,获得10
15秒前
Heeyeon发布了新的文献求助10
15秒前
Divine完成签到,获得积分10
15秒前
小白发布了新的文献求助30
16秒前
张zz完成签到 ,获得积分10
17秒前
17秒前
20秒前
星辰大海应助紫苑采纳,获得20
21秒前
Nakjeong完成签到 ,获得积分10
22秒前
dragonhmw完成签到 ,获得积分10
22秒前
维夏十一发布了新的文献求助10
22秒前
LTJ完成签到,获得积分10
24秒前
25秒前
顽主完成签到,获得积分10
25秒前
26秒前
28秒前
28秒前
GlockieZhao完成签到,获得积分10
28秒前
Kevin完成签到,获得积分10
28秒前
Jasper应助爱lx采纳,获得10
29秒前
婷婷发布了新的文献求助30
31秒前
万能图书馆应助麻生采纳,获得10
33秒前
紫苑发布了新的文献求助20
33秒前
kdjm688完成签到,获得积分10
33秒前
wyz完成签到 ,获得积分10
34秒前
hailicy发布了新的文献求助10
34秒前
丁丁完成签到 ,获得积分10
35秒前
yuling完成签到,获得积分10
35秒前
陈腿毛完成签到,获得积分10
38秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
Near Infrared Spectra of Origin-defined and Real-world Textiles (NIR-SORT): A spectroscopic and materials characterization dataset for known provenance and post-consumer fabrics 610
Promoting women's entrepreneurship in developing countries: the case of the world's largest women-owned community-based enterprise 500
Shining Light on the Dark Side of Personality 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3307193
求助须知:如何正确求助?哪些是违规求助? 2940961
关于积分的说明 8499766
捐赠科研通 2615195
什么是DOI,文献DOI怎么找? 1428732
科研通“疑难数据库(出版商)”最低求助积分说明 663525
邀请新用户注册赠送积分活动 648382